EBV-specific cytotoxic T lymphocytes (GRALE)

EBV-specific cytotoxic T lymphocytes · Baylor College of Medicine

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for EBV-specific cytotoxic T lymphocytes (GRALE), covering 2026-03-02 to 2026-03-02. Get the full timeline:

Most recent: Clinical Trial Update: Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE [Phase 1]